Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ER.

Aims: To assess fesoterodine 8 mg efficacy over time and vs. placebo in subjects with overactive bladder (OAB) who responded suboptimally to tolterodine extended release (ER) 4 mg.Methods: In a 12-week, double-blind trial, subjects with self-reported OAB symptoms for ≥ 6 months, mean of ≥ 8 micturit...

Descripción completa

Detalles Bibliográficos

Publicado en:	International Journal of Clinical Practice Vol. 68; no. 9; pp. 1065 - 1074
Autores principales:	Kaplan, S A, Cardozo, L, Herschorn, S, Grenabo, L, Carlsson, M, Arumi, D, Crook, T J, Whelan, L, Scholfield, D, Ntanios, F
Formato:	clinical trial research Journal Article
Publicado:	Wiley-Blackwell Sep2014
Acceso en línea:	Ver este registro en EBSCOhost